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Follicular dendritic cells (FDCs) are unique immune cells that contribute to the regulation
of humoral immune responses. These cells are located in the B-cell follicles of secondary
lymphoid tissues where they trap and retain antigens (Ags) in the form of highly
immunogenic immune complexes (ICs) consisting of Ag plus specific antibody (Ab)
and/or complement proteins. FDCs multimerize Ags and present them polyvalently to
B-cells in periodically arranged arrays that extensively crosslink the B-cell receptors for
Ag (BCRs). FDC-FcγRIIB mediates IC periodicity, and FDC-Ag presentation combined with
other soluble and membrane bound signals contributed by FDCs, like FDC-BAFF, -IL-6,
and -C4bBP, are essential for the induction of the germinal center (GC) reaction, the
maintenance of serological memory, and the remarkable ability of FDC-Ags to induce
specific Ab responses in the absence of cognate T-cell help. On the other hand, FDCs
play a negative role in several disease conditions including chronic inflammatory diseases,
autoimmune diseases, HIV/AIDS, prion diseases, and follicular lymphomas. Compared to
other accessory immune cells, FDCs have received little attention, and their functions
have not been fully elucidated. This review gives an overview of FDC structure, and
recapitulates our current knowledge on the immunoregulatory functions of FDCs in health
and disease. A better understanding of FDCs should permit better regulation of Ab
responses to suit the therapeutic manipulation of regulated and dysregulated immune
responses.
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INTRODUCTION
In 1968, Andras K. Szakal and Michael G. Hanna, Jr. (Szakal
and Hanna, Jr., 1968) from the Oak Ridge National Laboratory,
Tennessee, USA; and Gustav J. Nossal et al. (Nossal et al., 1968)
from the Walter and Eliza Hall Institute in Melbourne, Australia,
published the first electron micrographs and description of FDCs.
A number of names have been used, but a committee on nomen-
clature recommended the name “Follicular Dendritic Cell” and
the abbreviation “FDC,” and this has been generally adopted (Tew
et al., 1982).
The characteristics that distinguish FDCs from other cells
of the immune system are their ability to retain antigen (Ag)-
antibody (Ab)-complement complexes (i.e., immune complexes,
ICs) long-term on their surfaces and their follicular localization.
Unlike other immune accessory cells, FDCs lack phagocytic activ-
ity, lysosomes, lysozyme, and Birbeck granules. FDCs localized to
the follicles of secondary lymphoid tissues form interactive net-
works or reticula of non-mobile Ag-bearing cells. Immobile FDCs
in these FDC-reticula engage the mobile B and T-cells and other
mobile cells trafficking through the follicles (Szakal et al., 1985; El
Shikh et al., 2010).
FDCs in germinal center (GC) light zones of B-cell follicles
(Figures 1 and 2) retain ICs via the complement receptors
(CR1/CR2—CD35/CD21), the low affinity immunoglobulin
gamma Fc region receptor II-B (FcγRIIB/CD32) and the
low affinity immunoglobulin epsilon Fc region receptor II
(FcεRII/CD23). In addition, FDC dendrites bear complement 3
(C3) fragments (iC3b, C3d, and C3dg) attached to the ICs and
adjacent cell membranes via ester linkages at the FDC-B-cell
interface. Engagement of BCRs with FDC-retained Ags is critical
for GC development, B-cell survival, Ig class switching, produc-
tion of B memory cells, somatic hypermutation (SHM), selection
of somaticallymutated B-cells with high affinity receptors, affinity
maturation, induction of secondary Ab responses, and regulation
of serum IgG and IgE levels. Moreover, FDCs exert a pivotal role
in organizing the lymphoidmicro-architecture, and abrogation of
FDC networks as a consequence of ablation of Lymphotoxin (LT)
trimers and Tumor Necrosis Factor-α (TNF-α), either through
homologous recombination or by pharmacological means, abol-
ishes the sophisticated lymphoid architecture compartmentaliza-
tion (Kosco-Vilbois, 2003; Allen and Cyster, 2008; El Shikh et al.,
2009b, 2010).
FDCsmultimerize intact monomeric proteins and present Ags
in ICs to B-cells with regular periodicity in vivo and in vitro. ICs
trapped via FDC-FcγRIIB in the absence of complement are dis-
played in a periodic manner with 200–500 Å spacing between epi-
topes (Szakal et al., 1985; Sukumar et al., 2006b, 2008). In contrast
to proteolysis and the MHC-restricted peptide presentation by
DCs to T-cells, and similar to T-cell-independent (TI) type 2 Ags
and higher order protein arrays, FDCs display native monomeric
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FIGURE 1 | Murine FDCs in lymph node (LN) GCs. (A) Activated GC
B-cells labeled with the mAb GL7 (green) are surrounded by a mantle of
CD45Rhi (magenta) resting B-cells in two adjacent secondary B-cell follicles
in the draining LNs of an immunized mouse. (B) These GC B-cells
downregulate CD45R expression upon activation. (C and D) The activated
GC B-cells are intimately associated with FDC Ag retaining reticulum (blue).
(E) High magnification of the FDC reticulum retaining AMCA-conjugated
ovalbumin (blue).
FIGURE 2 | Human FDCs in tonsillar sections trapping IgG/C3-
opsonized Ags in ICs. (A and B) Two B-cell follicles surrounded by resting
IgD+ mantle B-cells (blue, insets in the right upper corner). The overlay of
FDCs in the follicles (labeled green with CNA.42mAb) and the FDC-trapped
ICs (labeled red with anti-human IgG in the upper panel and anti-C3 in the
lower panel) is orange-yellow. (C and D) FDCs labeled green with the
FDC-specific mAb CNA.42. (E) Human IgG in the FDC-trapped ICs labeled
red with anti-human IgG. (F) Human C3 in FDC-trapped ICs labeled red with
anti-human C3.
proteins as multimerized ICs with repeating immunogenic epi-
topes thus allowing extensive BCR cross-linking and induction of
rapid B-cell activation, proliferation, GC formation, and Ig secre-
tion to T-cell-dependent (TD) Ags in a TI manner. In addition
to this FcγRIIB-dependent Ag presentation, FDC-derived B-cell
Activating Factor of the TNF family (BAFF) and C4b-binding
protein (C4bBP) are critical for TI B-cell activation (El Shikh
et al., 2009a, 2010).
Engagement of BCRs by free Ag can induce B-cell activa-
tion; however, an immunogen is converted into ICs as soon as
Ab is produced in a primary response, and instantaneously in
recall responses by Ab persisting from previous immunizations.
IgG-ICs coligate BCR with FcγRIIB and inhibit B-cell activation
via the tyrosine-based inhibitory motif (ITIM). In contrast, IgG-
ICs trapped by FDC-FcγRIIB do not engage B-cell-FcγRIIB and
consequently ITIM-mediated signaling is minimized (Tew et al.,
1976, 2001; Qin et al., 2000; Aydar et al., 2003, 2004b; El Shikh
et al., 2006).
Not only FDCs provide the necessary Ag for B-cell stimula-
tion but they orchestrate the removal of self-Ags released from
apoptotic cells in the GC environment. FDCs secrete the bridg-
ing factor Mfge8, which crosslinks apoptotic cells in the GCs
and the phagocytic “tingible body macrophages” (TBMs). This
promotes selective debris removal and engulfment of dead cells.
Mice lacking LT or LT receptors, which are devoid of FDCs, or
lacking the bridging protein Mfge8 itself, are significantly suscep-
tible to autoimmunity suggesting the role of FDCs in protection
against autoimmunity by expediting the removal of potentially
self-reactive debris from the GCs (Kranich et al., 2008).
Beyond their immunoregulatory functions, FDCs are criti-
cally involved in the pathogenesis of several diseases. FDCs are
important HIV reservoir where FDC-trapped HIV persists for
long periods and can reignite infection and perpetuate the dis-
ease (Smith et al., 2001). Moreover, FDCs are the essential sites
of prion replication in lymphoid tissues (McCulloch et al., 2011),
and they provide a microenvironment that supports B-cell lym-
phomas and establish a protective sanctuary for malignant cells
from otherwise effective drugs (Lee et al., 2012).
In addition, several lines of evidences support the critical role
of FDCs in the pathogenesis of autoimmune diseases. Chronic
inflammatory autoimmune disorders frequently display follicles
with IC-bearing FDCs, autoreactive GCs, and ongoing affinity
maturation (Aloisi and Pujol-Borrell, 2006; Manzo et al., 2010).
Moreover, interference with FDC reticula attenuates autoreactive
GC formation, reduces pathogenic auto-Ab titers and mem-
ory B lymphocytes and ameliorates arthritis (Gray and Skarvall,
1988; Gray, 1993; Barrington et al., 2002; Anolik et al., 2008;
Victoratos and Kollias, 2009; Vinuesa et al., 2009; Manzo et al.,
2010).
In this review we address the current knowledge about the
structure and function of FDCs and their role in immune reg-
ulation in health and disease.
FDC MORPHOLOGY, DEVELOPMENT, Ag RETENTION,
AND ISOLATION
FDC MORPHOLOGY
Light and electron microscopy studies of FDCs have revealed
structural details that help clarify FDC functions. FDCs are
slightly larger than lymphocytes and possess many fine den-
dritic processes. These dendrites extend and intimately interact
with neighboring cells, creating a unique microenvironment.
This intimate interaction with surrounding lymphocytes appears
to be important for FDCs to provide potent signals that pro-
mote humoral immune responses. Scanning electron microscopy
(SEM) has identified two morphological types of FDCs: one
having filiform or finger-like processes, and one with “beaded”
dendrites. The transition from one form of FDC into another
appears to be related to the formation of a specialized Ag
delivery system. The resulting “beads” are called “iccosomes”
to denote that they consist of immune complex-coated bodies
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(Schnizlein et al., 1985; Szakal et al., 1985; Sukumar et al., 2006b,
2008; El Shikh et al., 2007a).
FDCs possess a scanty cytoplasm with few mitochondria,
rough endoplasmic reticulum, a Golgi apparatus, and vesicles.
They have irregular, sometimes bilobed, euchromatic nuclei con-
taining distinct nucleoli. The dendritic processes of FDCs appear
in two general forms: some are attenuated, with folds and inter-
mittent thickenings that form a variety of differently shaped
cytoplasmic extensions, while others form more uniform, highly
convoluted, labyrinthine configurations. These dendritic pro-
cesses interdigitate with one another and form a vast network
or reticulum on which ICs are trapped (Schnizlein et al., 1985;
Szakal et al., 1985; Sukumar et al., 2006b, 2008; El Shikh et al.,
2007a).
FDC ORIGIN, DEVELOPMENT, AND LYMPHOID TISSUE ORGANIZATION
The cellular origin of FDCs is still controversial and various cell
types have been proposed as a possible origin of FDCs. FDCs,
at least in their mature form, are stationary, however, the pos-
sibility of an inflow of earlier progenitors of FDCs from other
sites could not be fully excluded (Kasajima-Akatsuka and Maeda,
2006).
At present there are data supporting a haematopoietic origin
and more data supporting a stromal cell origin. FDCs are radi-
ation resistant making it difficult to study development using
adoptive transfer models. Information available on FDCs is based
primarily on studies using humans and rodents. However, FDCs
are present and functional in birds and if FDCs are defined
broadly as cells with the ability to trap ICs, they appear to exist
in all jawed vertebrates, including amphibians, reptiles, and fish
(El Shikh et al., 2009b).
Using mice homozygous for the SCID mutation, which lack
T, B lymphocytes, and FDCs, demonstrated that after reconsti-
tution with bone marrow from donor mice, the FDCs of the
reconstituted mice expressed the donor phenotype. These authors
concluded that FDC precursors came from bone marrow (Kapasi
et al., 1993a,b, 1994; Szakal et al., 1995a,b; Kapasi et al., 1998).
On the other hand, stromal cells expressing FDCmarkers have
been described in several independent studies, and seem to be
present in the splenic white pulp before the development of func-
tionally and ultrastructurally recognizable FDC. Using an in silico
subtraction approach, gene expression of FDCs was determined
and compared with that of follicular stromal cells microdissected
from the spleen of SCID mice and a remarkably close relation-
ship in gene expression patterns was found (Wilke et al., 2010).
However, one of the major limitations in the study of FDC ori-
gin is the paucity in markers specific for the various stages of
FDC maturation that would allow for discriminating FDC pre-
cursors from B-cells as well as from other stromal cells (Aguzzi
and Krautler, 2010; Wilke et al., 2010).
Recent transcriptome analysis showed that FDCs express many
mesenchyme-associated genes suggesting that FDCs are special-
ized mesenchymal cell population within the GCs of lymphoid
tissues (Mabbott et al., 2011). It was also suggested that cytokines
from lymphocytes and macrophages involved in inflammatory
process may be responsible for differentiating stromal cells into
a FDC phenotype (Cho et al., 2012a).
Another recent study has suggested a mechanism of FDC
development that involves both resident and migratory cells.
Specifically, it was proposed that a FDC is generated by a
cell fusion event between a stromal cell and a migratory
CD35+B220+ precursor cell, which is consistent with several
observations of binucleate FDCs (Murakami et al., 2007; Allen
and Cyster, 2008). Moreover, differentiation of FDCs as a special-
ized form of myofibroblasts that derive from bone marrow stro-
mal cell progenitors has been also suggested (Munoz-Fernandez
et al., 2006; Sipos and Muzes, 2011).
TNF and the related molecule LT are essential for FDC devel-
opment, and mice deficient in these cytokines, their receptors,
or associated downstream signaling molecules fail to properly
develop FDCs and GCs in secondary lymphoid organs. Through
irradiation chimera and adoptive transfer experiments, it was
established that TNF and LT were required on lymphocytes,
specifically B-cells for normal FDC development. The differential
role of soluble and membrane bound TNF in FDC development
has been also investigated with more significant role of soluble
TNF in FDCdevelopment in primary follicles and themembrane-
bound TNF form in FDCs of the GCs (Allen and Cyster, 2008;
Tumanov et al., 2010).
FDCs helpmaintain primary follicles as a B-cell exclusive niche
and they act to retain and promote the survival of GC B-cells
within GCs. Within two days of FDC ablation, primary B-cell
follicles lose their homogeneity and become disorganized bands
of cells around T zones. Ablation of FDCs during the GC response
causes rapid GC B-cell dispersal, death, and disappearance of the
GCs (Wang et al., 2011).
The cardinal feature of FDCs is the surface retention of native
Ags for extended periods of time and presentation of these Ags
together with costimulatory signals to B-cells during normal
and abnormal immune responses. This unique property of Ag
retention and presentation by FDCs: (1) occurs in different sites
of secondary lymphoid tissues, including the spleen, LNs, and
mucosa-associated lymphoid tissues (MALT); (2) can be induced
in tertiary lymphoid tissues in different organs as a consequence
of chronic inflammatory and autoimmune reactions; (3) depends
on Ag retention on FDCs, which is directly associated with differ-
ent Ag transport mechanisms in secondary and tertiary lymphoid
tissues; (4) can be induced in cells of haematopoietic and stromal
origin under physiological and pathological conditions in vivo
and in vitro. Consequently, the origin of FDCs may be differen-
tially regulated in different anatomical sites, under different sets
of microenvironmental conditions, and by the cells and routes
that deliver the Ag to the FDC reticulum. Our knowledge is still
expanding in the field of FDC biology and more needs to be
investigated in the processes of FDC differentiation and themech-
anisms of Ag transport to their reticula in different anatomical
locations before a final conclusion can be drawn on their origin.
Ag TRANSPORT TO THE FDC RETICULUM
A notable feature of the FDC network is that it is located centrally
in the follicle and typically does not extend to the subcapsular
sinus (SCS), interfollicular regions or T-cell zone. The logic for
this separation of FDCs from the sites of earliest Ag capture has
not been defined but it prompted studies on the mechanisms
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of Ag transport to the FDC reticulum dating back to the early
1980s.
Perhaps being centred in the follicle and not in substantial
contact with macrophages, DCs, or circulatory fluids provide a
protected environment in which opsonized Ags can be displayed
for long periods without being proteolysed or removed by phago-
cytic cells. However, the physical isolation of FDCs in follicles
necessitates mechanisms for Ag to travel from the first point of
capture to the FDC (Cyster, 2010).
In the early 1980s, elegant light and electron microscopic stud-
ies indicated that as early as 1min after Ag injection in passively
immune mice, localization of Ag occurs at distinct sites in the
SCS and subjacent areas of the cortex on the afferent side. At
these sites, between 1min and 24 h, the Ag forms light microscop-
ically identifiable trails which reaches progressively deeper into
the cortex with time toward individual follicular regions. By 24 h
this apparent migration of Ag is complete, and the Ag is local-
ized in follicles. Electron microscopy indicated that the apparent
migration of ICs was mediated by a group of cells observed in
the migration path that had ICs sequestered on their surface or in
plasma membrane infoldings. These Ag transporting cells (ATC)
were relatively large non-phagocytic cells, with lobated or irregu-
lar euchromatic nuclei and cell processes of various complexities.
ATCs observed in or near the SCS appeared to be less differ-
entiated, whereas those located deeper in the cortex, appeared
more differentiated, interdigitated with Ag-retaining dendritic
cells, and shared morphologic characteristics with FDC (Szakal
et al., 1983).
More recently, it was reported that large MW proteins
(>60 kDa) injected into passively immune mice form ICs that
activate complement, resulting in covalent attachment of C3
(C3-IC). SCS macrophages (SCSM) have a low rate of Ag inter-
nalization and degradation (Cyster, 2010), and the C3-coated ICs
are shuttled via the SCSM-CR3 onto naïve B-cell-CR1/2-CD32
that migrate to the FDC reticulum and off-load the ICs to the
FDC-CR1/2-CD32. In the absence of pre-existing specific Abs,
innate recognition proteins such as natural IgM; C-type lectins
such as MBL and ficolins; pentraxins, including C-reactive pro-
tein; and other complement activators could effectively bind the
foreign protein and activate complement, then the C3-coated ICs
follow the SCSM-CR3/naïve B-cell-CR1/2-CD32/FDC-CR1/2-
CD32 transport mechanism. C3-coated smaller MW proteins
access the B-cell follicles via the follicular conduits that intersect
with FDCs, providing a direct connection for C3-coated Ags to
bind to the FDC surface via CR1/2-CD32. DCs residing in the
LN medulla may also capture C3-opsonized Ags and hand off the
complexes to FDCs in the B-cell follicle (Gonzalez et al., 2011).
It has been also reported that SCSM themselves transport ICs
directly to FDCs after immunization with Ag in adjuvant (Cyster,
2010), and the strategic positioning of FDCs around follicular
conduits in the B-cell follicles of the LNs gives them direct access
to capture soluble Ags draining from subcutaneous sites even in
the absence of Ag-specific Abs (Bajenoff and Germain, 2009).
Both marginal zone (MZ) B and B-1-cells help reorganization
of FDC networks (Ferguson et al., 2004; Lopes-Carvalho et al.,
2005) and B-1-cells promote the development of FDCs retic-
ula (Wen et al., 2005). The continuous shuttling of MZ-B-cells
to B-cell follicles has been recently documented and the poten-
tial interaction between MZ-B-cells and Ags in ICs on FDCs has
been proposed (Cinamon et al., 2008; MacLennan, 2008). In the
spleen, MZ-B-cells that express relatively high levels of CD21
and CD35 pick up C3-ICs from the sinus and deliver the com-
plexes to FDCs as they migrate though the follicles (Cinamon
et al., 2008; MacLennan, 2008; Gonzalez et al., 2011). Natural
and specific Abs differentially regulates Ag transport in the spleen.
Particulate proteins expressed on virus-like particles were trans-
ported efficiently to murine splenic FDCs in the absence of prior
immunity via natural IgM Abs and complement, whereas sol-
uble proteins required Ag-specific IgM or IgG Abs (Link et al.,
2012).
FDC ISOLATION AND in vitro GC REACTIONS
Major challenges delayed the systematic analysis of FDC func-
tions in health and disease. Retrieval and characterization of
FDC-retained Ags, isolation of the Ag-retaining FDCs, detec-
tion of picogram quantities of Ags in GCs, and the lack of
in vitro models for GC reactions represented major technical
difficulties in investigating the biology of FDCs. The current
development of FDC isolation techniques with >90% purity
(Sukumar et al., 2006b), and methods for setting up GC reac-
tions in vitro (El Shikh et al., 2007b, 2009a; Wu et al., 2008,
2009); where the influence of Ags, ICs, FDC-, T-cell-, and
B-cell-regulatory molecules can be manipulated at will; provide
a pathway to analyse the molecular interaction between the cel-
lular and molecular components of the GC reaction. Based on
the lack of CD45 expression, a recent study described a novel
method for FDC isolation from the spleen of naive mice by
flow cytometry. The isolated FDCs, which accounted for ∼0.2%
of the spleen cells of naive mice, were CD45−, FDC-M2+, and
ICAM-1+, and supported the survival and LPS-induced prolifer-
ation of B-cells via FDC-BAFF-dependent pathway (Usui et al.,
2012).
FDCs are fragile cells and are tightly associated with B-cells
which hamper the process of FDC isolation. Several FDC lines
were established to overcome these problems, however, as these
cells aremaintained over several weeks in culture, their phenotype
no longer reflects the in vivo situation (Aguzzi and Krautler, 2010;
Wilke et al., 2010). FDCs require constitutive LT-R-mediated
stimulation from surrounding lymphocytes to maintain their
maturation status. In the absence of this stimulation FDC rapidly
dedifferentiate (Mabbott et al., 2011).
Artificial engineering of lymphoid tissue equivalents is an
emerging field that aims to provide models for therapeutic appli-
cations of vaccines, and drugs used in the treatment of chronic
inflammation, autoimmunity, and cancer. Being the hotspot of
Ab production, more work on developing in vitro GC reactions
is critical for these artificial lymphoid tissues (Tan andWatanabe,
2010).
T-CELL-DEPENDENT (TD) AND INDEPENDENT (TI)
ANTIGENS, THE GERMINAL CENTER REACTION (GCR),
AND THE IMMUNOREGULATORY FUNCTIONS OF FDCs
FDCs critically regulate Ag presentation to B-cells in the GCR. In
the following section we will introduce the types of Ags and the
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GCR before we discuss the specific immunoregulatory functions
of the FDCs.
TD AND TI Ags
Long before T and B lymphocytes were discovered, it was known
that certain Ags of bacterial origin were fundamentally differ-
ent from protein Ags. Lipopolysaccharide (LPS), for example,
was found to be immunogenic at very low concentrations and
even 1000 molecules could induce a detectable immune response
dominated by 19S Abs (IgM) (Moller, 1965; Landy and Baker,
1966).
With regard to their capacity for Ab-induction, Ags are classi-
fied as T-cell dependent (TD) or T-cell independent (TI). In the
immune responses to TD Ags, provision of cognate T-cell help to
B lymphocytes is essential for B-cell proliferation, immunoglob-
ulin (Ig) secretion, class switch recombination (CSR), affinity
maturation, and memory B-cell generation. On the contrary, TI
Ags induce B-cell activation and Ab production without T-cell
help. TI Ags are further divided into TI type 1 Ags (TI-1), which
are polyclonal B lymphocyte activators, and TI type 2 (TI-2) Ags
which are classically polysaccharides fit for extensive crosslinking
of multiple BCRs.
Protein Ags without repetitive epitopes require cognate T-cell
help to induce high affinity B-cell immunity. These TD Ags are
processed and presented by Ag presenting cells (APCs) which
activate Ag-specific helper T (Th) cells in the T-cell zones of
secondary lymphoid tissue. Activated Th cells expand and differ-
entiate into effector Th cells that regulate the development of Ag
primed B-cells. Under Th cell control, these primed B-cells can
switch Ig isotype, terminally commit to the plasma cell pathway or
enter the GCR to experience cycles of SHM, affinity maturation,
selection of high affinity B-cells, and memory B-cell generation.
Ag-specific Th cells contribute to the GCRs where they critically
regulate the affinity-based selection of memory B-cells. A long-
lived memory Th cell compartment is established in the immune
responses to TD Ags, where Ag rechallenge induces exaggerated
cellular expansion in the memory B and T-cell compartments
(Parker, 1993; McHeyzer-Williams et al., 2003; Jeurissen et al.,
2004).
A complex mixture of TD Ags (peptides and proteins) and
TI Ags (glycolipids and complex polysaccharides) are present in
microorganisms (Leyva-Cobian et al., 1997). Pathogen-associated
TI-1 Ags are polyclonal B-cell activators most of them are derived
from components of the cell membranes, the cytosol, or excre-
tion/secretion products of bacteria, viruses, and parasites. The
Abs secreted by B-cells stimulated with polyclonal activators
are non-specific and recognize heterologous as well as homol-
ogous Ags. The molecular mechanisms triggered by polyclonal
activators derived from microorganisms have not been eluci-
dated completely; however, several lines of evidences support
that these molecules are able to activate B-cells through TLRs.
For example, DNA or oligodeoxynucleotides containing CpG
motifs [CpG-oligodeoxynucleotide (ODN)] act via the intracel-
lular receptor TLR-9. Conversely, LPS in complexes with the
LPS-binding protein (LPSBP) is captured by CD14 which then
associates with the TLR-4-myeloid differentiation protein 2 com-
plex on B-cells. This initiates signaling pathways, which involve
MyD88, and also leads to the activation of NF-κB (Baumgarth,
2000; Montes et al., 2007). Induction of TI GCRs by certain
pathogen-associated Ags can promote expansion of B-cell clones
expressing V regions selected over evolutionary time to recognize
common multivalent structures on the surface of such pathogens.
Because SHM does not take place efficiently in TI GCRs, the
specificity of the selected V regions would not be altered, and
such a process would not pose a threat to self tolerance (Manser,
2004).
TI-2 Ags are classically large MW polysaccharides displaying
repeating immunogenic epitopes with poor biodegradability, and
complement fixation ability. These Ags can crosslink BCRs and
stimulate Ab production by mature B-cell in athymic nude mice
lacking MHC class II restricted T-cell help [detailed in (Dintzis
et al., 1976, 1982; Brunswick et al., 1988, 1992; Mond et al., 1995;
Sulzer and Perelson, 1997; de Vinuesa et al., 2000; Vos et al., 2000;
Lentz and Manser, 2001; Zubler, 2001)].
In spite of their chemical diversity, structural analysis of clas-
sic TI-2 Ags has shown that all share a minimal MW of 100 kDa
and repetitive epitopes that are expressed on a stable back-
bone with a two-dimensional epitope spacing of 95–675 Å. An
extended length of the backbone of 460 nm, carrying 48 epitopes
engaging 10–50mIg receptors forming a small number of highly
crosslinked clusters of mIg molecules with 14-fold reduction in
the diffusion coefficient of the bound mIg receptors is critical for
delivering the BCR-mediated signal in TI-2 responses (Vos et al.,
2000).
In view of recent studies, the operational characteristics of
TI-2 Ags have been extended beyond classic polysaccharides.
Reports on the requirements for generation of Ab responses to
repetitive determinants on polymers and higher order structures
such as viral capsid proteins indicated that high MW arrays of
Ag are efficient in eliciting Ab responses independent of T-cell
help, whereas their less ordered counterparts are less immuno-
genic and require T-cell help (Dintzis et al., 1983; Bachmann
and Zinkernagel, 1997). Data from several viral models including,
Coxsackie, influenza, foot-and-mouth disease, vesicular stomati-
tis, and Sindbis viruses, indicate that virus-specific IgM responses
are mounted when athymic nude, TCRα- TCRβ- TCRαβ- and
TCRαβγδ-knockout mice are infected. All of the antiviral TI Ab
responses reported so far are directed to viral Ags repetitively
displayed in the virions (Szomolanyi-Tsuda and Welsh, 1998).
Moreover, Abs bound to strictly ordered, but not to irregularly
arranged, viral Ags dramatically enhanced the induction of anti-
Abs after a single immunization and without using adjuvants
(Fehr et al., 1997). Similar to TI-2 Ags, and higher order protein
arrays on viral capsids, the ability of FDCs to retain ICs in a peri-
odic manner allows multimerization of monomeric proteins that
generally express only a single copy of each antigenic determinant
and facilitates the multivalent presentation of these determinants
in an array fit for crosslinking of multiple BCRs and induction of
Ab responses in the absence of T-cell help (El Shikh et al., 2009a,
2010).
A clinically important group among the TI-2 Ags are the
bacterial capsular polysaccharides. Capsular polysaccharides of
Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria
meningitidis are responsible for the bacterial virulence; and Abs
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to capsular polysaccharides provides protection against inva-
sive infections with these bacteria. Maturation of the immune
response to TI-2 Ags in humans is delayed. The delay in Ab forma-
tion to encapsulated bacteria renders infants and young children
highly susceptible to infections with encapsulated bacteria, espe-
cially from the age of 4 to 6months on, when the placenta-derived
maternal IgG is metabolized. Therefore, children younger than
2 years of age are more at risk for invasive infections caused by
encapsulated microorganisms (Jeurissen et al., 2004).
TI B-cell activation is further discussed in the immunoregula-
tory functions of FDCs.
THE GCR
GCs are highly structured tissue microdomains in activated B-cell
follicles wherein B lymphocytes undergo clonal expansion, CSR,
Ab gene diversification, and affinity maturation.
GCs were first observed in 1884 by Flemming and his asso-
ciates who concluded that GCs were one of the major sources of
lymphocytes throughout the body. Though the name given to the
sites of intense proliferation in the follicles is still used, we now
know that the conclusion that the cells originate/germinate within
the GC is not true. The term “reaction” in GCR is used to stress
the reactive nature of the GC response, i.e., the development (and
decline) of a GC as a result of antigenic stimulation (Nieuwenhuis
and Opstelten, 1984).
GCRs differ slightly from organ to organ and from species to
species. GCs also form in atypical sites (referred to as tertiary lym-
phoid tissues) such as in the stomach during Helicobacter pylori
infections, the eye during Chlamydia infections, blood vessels
in atherosclerosis, joints in rheumatoid arthritis, the thyroid in
Hashimoto’s thyroiditis, and the lung in the chronic inflamma-
tory diseases of the respiratory system (Kosco-Vilbois et al., 1997).
GC formation is restricted to homoiothermic animals. Associated
with the ability to produce GCs in their lymphoid tissues, birds,
and mammals produce Abs of heterogeneous affinity, increas-
ing in the secondary as compared to the primary response. The
characteristic fast rise of serum Ab after a secondary injection
of Ag may provide a survival advantage in the defence against
pathogens that multiply more rapidly at the higher body tem-
perature (Thorbecke et al., 1994; Manser, 2004). Furthermore,
aging is associated with defective GCRs associated with abnor-
mal functions of the GC cellular components (Kosco et al., 1989;
Szakal et al., 1990, 1992, 2002; Smith et al., 1991; Tew et al., 1993;
Thorbecke et al., 1994; Zheng et al., 1997; Aydar et al., 2002, 2003,
2004a).
GCs arise in primary lymphoid follicles of secondary lym-
phoid tissues. The sites that become involved are those receiving
the antigenic stimulus via drainage of lymph, blood, or special-
ized cells in the epithelium called “M” cells. The GCR is a complex
process involving numerous cellular and cell surface components
together with multiple signaling pathways (Nieuwenhuis and
Opstelten, 1984; MacLennan, 1994; Kosco-Vilbois et al., 1997;
Cozine et al., 2005; Vinuesa and Cyster, 2011).
The primary B-cell follicle contains a mixture of recirculat-
ing naïve and memory B-cells. Upon B-cell activation in the
T-cell zone, a few committed Ag specific B-cells migrate into
the follicle and expand clonally. Several studies indicated that
low numbers of Ag-specific B-cells can be seen within the folli-
cles in the primary response as early as 36 h post-immunization.
Three to four Ag-specific B-cells colonize a follicle and go through
repeated rapid cell cycles increasing some 4000-fold in around
three days. In doing this, they fill the spaces between the network
of FDCs. Within 72–84 h of exponential growth the cells differ-
entiate to form a mature GC chracterized by the presence of a
light zone and a dark zone. The proliferating cells move to one
pole of the GC and become centroblasts. Centroblasts produce
non-proliferating centrocytes that are thought to migrate to the
light zone of the GC, which is rich in Ag-trapping FDCs and T
follicular helper (Tfh) cells. Small, non-cycling follicular B-cells
are then moved closer together, forming the follicular mantle.
The light zone contains a rich network of FDCs that have the
capacity to take up Ag and hold it on their surface for periods
of more than a year. The Ag is held as an IC in a native unpro-
cessed form; but the Ag may be taken up from FDC by B-cells,
which can process and present it to T-cells. The open structure
of GCs allows high-affinity Ag-specific B-cells to be recruited to
an ongoing GCR. This enhances competition for the FDC-bound
Ags and ensures that rare high-affinity B-cells can participate
in Ab responses (MacLennan, 1994; Kosco-Vilbois et al., 1997;
MacLennan et al., 2000; McHeyzer-Williams, 2003; Natkunam,
2007; Schwickert et al., 2007).
One of the hallmarks of the GCR is the introduction of somatic
mutations into IgV genes of GC centroblasts, mainly single base
pair mutations, followed by an efficient selection procedure that
ensures selection of Abs with higher affinity (Song et al., 1998;
McHeyzer-Williams et al., 2000; Chan and Brink, 2012). SHM
adds as many as one mutation per cell per division which pro-
vides a substrate for selection of higher affinity and more diverse
populations of cells. SHM can result in increased affinity of the
BCR for Ag, a critical event in affinity maturation and the pro-
duction of high-affinity Abs. Conversely, SHM can cause loss
of affinity, or altered specificity with the acquisition of autore-
activity. Centroblasts continually give rise to non-proliferating
centrocytes, which enter the FDC network where they are sub-
jected to selection. The selection is based on the ability of a
centrocyte first to bind Ag held on FDC, and second to present
this in a processed form to CD4 T-effector cells, which are
sited toward the outer edge of the FDC network. Cells that
fail to undergo positive selection die by apoptosis, the default
pathway for centrocytes that do not receive selection signals.
Selection eliminates those cells that have lost Ag-binding activ-
ity, or have acquired autoreactivity (MacLennan et al., 2000;
McHeyzer-Williams, 2003; Tarlinton, 2008; Vinuesa and Cyster,
2011; Shlomchik andWeisel, 2012b).
Upon exiting the GCR, selected B-cells can differentiate
into two long-lived compartments; memory B-cells, and bone
marrow-resident plasma cells. Both cell populations participate
in sustaining high-titred Ab levels. Memory B-cells recirculate in
the periphery, where they can survive for decades in humans.
Upon re-encounter with the Ag for which they are specific, mem-
ory B-cells can rapidly proliferate and differentiate into plasma
cells secreting high affinity Abs. on the other hand, bone marrow-
resident long-lived plasma cells secrete Abs for long periods of
time (MacLennan et al., 2000; McHeyzer-Williams, 2003; Kallies
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et al., 2004; Tarlinton, 2008; Elgueta et al., 2010; Good-Jacobson
and Shlomchik, 2010; Vinuesa and Cyster, 2011; McHeyzer-
Williams et al., 2012; Peperzak et al., 2012; Shlomchik andWeisel,
2012a).
GCs persist for about 3 weeks following immunization
(MacLennan, 1994), however, in mice immunized with pro-
tein Ag in adjuvant (Shlomchik and Weisel, 2012b) and TI GC
responses to multimerized protein Ags on FDCs (El Shikh et al.,
2009a) the GC response can persist detectably for more that 8
weeks. Moreover, immunization with viruses induces long-term
GCs associated with proliferating Ag-specific B-cells (Tarlinton,
1998) and continuous influx of T-cells (Vinuesa et al., 2010). With
the demise of the GCR, the dendritic processes of the FDC form
tightly folded convolutions of membrane where the Ag is retained
extracellularly forming depots of FDC-retained Ags thatmay con-
tribute to the recall responses (Sukumar et al., 2008; El Shikh
et al., 2010).
The contribution of T-cells to the GCR has been studied
extensively as T-cell help to B-cells is a fundamental aspect of
adaptive immunity and the generation of immunological mem-
ory. Tfh cells differentiate in response to immunization or infec-
tion and provide help to GC B-cells. Tfh cells, initially described
in 2000–2001, are CD4+ T-cells that mature in a Bcl-6-dependent
manner and are capable of providing IL-21-dependent help to
B-cells for GC formation and switched Ag-specific Ab responses
(Vinuesa and Cyster, 2011). This population is characterized by
a core set of factors essential for their generation and function;
including Bcl-6, IL-21, and CXCR5 expression; CD28 costimula-
tion; ICOS ligation; and SAP-mediated interactions with cognate
B-cells (Fazilleau et al., 2009; Crotty, 2011; Nutt and Tarlinton,
2011; Linterman et al., 2012; Weinstein et al., 2012).
The original description of GCs entailed definite T-cell depen-
dency (Nieuwenhuis and Opstelten, 1984), however, recent stud-
ies indicated that high-affinity B-cells can be induced to form
large GCs in response to (4-hydroxy-3-nitrophenyl) acetyl (NP)-
Ficoll in the absence of T-cells (de Vinuesa et al., 2000; Lentz and
Manser, 2001). Moreover, FDC-retained TD Ags induce TI B-cell
activation and Ig secretion in responses costimulated by FDC-
BAFF and C4bBP (El Shikh et al., 2009a). Therefore, T-cells may
be required for latter stages of the GCR, but they are dispensable
for the induction and initial development of this response (Lentz
and Manser, 2001).
Several models have been proposed for the cellular dynamics
during the GCR (McHeyzer-Williams et al., 2000; McHeyzer-
Williams and McHeyzer-Williams, 2005; Allen et al., 2007; Or-
Guil et al., 2007), and although there is no typical GCs in terms
of size, recent studies indicated that GCs have typical cellu-
lar ratios attained during the established phase of the response
(Wittenbrink et al., 2011).
Autoreactive and malignant GC B-cells induce a unique class
of disorders because they originate from cells of the immune sys-
tem that divert from the normal maturation programmes, via
genetic rearrangements or somatic mutations. As SHM and gene
rearrangements are the physiological landmarks of Ag-driven GC
responses, the risk for genetic lesions (and hence autoimmu-
nity and malignant transformation) is exponentially enhanced
(Hollowood and Goodlad, 1998; Guzman-Rojas et al., 2002;
Vinuesa et al., 2009; Manzo et al., 2010). GC B-cells with low Ag
affinity and autoreactivity are eliminated via apoptosis and are
rapidly cleared by TBMs. Inefficient clearance of apoptotic cells
results in autoimmunity that is thought to be mediated by various
intracellular molecules possessing danger-associated molecular
patterns (DAMPs), including nuclear self-Ags. DAMPs can be
released from apoptotic cells undergoing secondary necrosis due
to disruption of the apoptotic cell clearance programmes within
the GCs (Rahman, 2011).
Although the enzyme activation-induced deaminase (AID)
is essential for creating Ab diversification by causing mutations
during the GCR, it also greatly enhances the chance of B-cell
lymphoma development. AID increases the mutation rate to one
per thousand bases, six orders of magnitude more than spon-
taneous mutagenesis, and can ultimately lead to mutations of
proto-oncogenes and chromosomal translocations resulting in a
wide variety of B-cell lymphomas that are thought to derive from
GC B-cells based on their carrying somatically mutated V region
genes (Peperzak et al., 2012; Shlomchik andWeisel, 2012b).
In tertiary lymphoid tissues, infiltrating B- and T-lymphocytes
organize themselves into ectopic follicles and GCs. This has been
observed in several autoimmune, chronic inflammatory, and neo-
plastic diseases. Ectopic GCs are architecturally similar to GCs in
conventional secondary lymphoid organs, and comprise prolif-
erating B-cells and networks of FDCs. T-cells are also a regular
component of ectopic GCs where they provide cognate T-cell help
required for the progression of the GC B-cell response (Aloisi and
Pujol-Borrell, 2006; Carragher et al., 2008).
Although some elements of the cellular interactions between
cell types within GCs have now been visualized, it is yet to attain
the ability to image over extended time periods in order to have
clearer image of the GC kinetics.
THE IMMUNOREGULATORY FUNCTIONS OF FDCs
Ag presentation
Studies of TD Ags including ovalbumin, horseradish peroxidase,
and human serum albumin indicated that these immunogens
are almost instantaneously converted into ICs by Abs persisting
from prior immunization(s).Moreover, in primary responses, ICs
form as soon as Ab is produced and these ICs are trapped in
the FDC reticula. Ag trapping and retention is exquisitely local-
ized to draining lymphoid tissues. Ag injection into a single limb
of an immune mouse will be localized to the draining LNs and
to a lesser extent in the spleen (Mandel et al., 1980; Donaldson
et al., 1986). With time, the Ag persisting on FDCs becomes
more and more focused to the lymphoid follicles nearest the
site of Ag injection and by 1 year, specific Ab forming cells are
almost exclusively confined to the most proximal LN (Donaldson
et al., 1986). Remarkably, once Ags are trapped on FDCs, they
remain relatively unaffected by a variety of manipulations includ-
ing gamma-irradiation, stress, and treatment with a number of
anticancer drugs. However, cortisone acetate injections result in
the loss of a significant portion of persisting Ag although the
reason for this remains unclear (El Shikh et al., 2009b).
FDCs trap ICs via Fc andC receptors (Tew et al., 2001; El Shikh
et al., 2006). In the spleen, Ag retention requires the presence
of complement (Klaus and Humphrey, 1977; Tew et al., 1979),
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whereas, in the draining LNs, FDCs are capable of trapping ICs
in the absence of complement (Tew et al., 1979; El Shikh et al.,
2006). Complement-mediated IC trapping in the draining lymph
nodes of FcγRIIB−/− mice is normal compared to WT controls
although retention of ICs over time is reduced in FcγRIIB−/−
mice suggesting FcγRIIB is important in long-term maintenance
of the ICs (Tew et al., 1976). Remarkably, engagement of FDC-
FcγRIIB with ICs plays a critical role in activating FDCs. Binding
of ICs to FDC-FcγRIIB induces FDC activation which leads to
dramatic upregulation of FDC-ICAM-1, -VCAM-1 and -FcγRIIB
itself (El Shikh et al., 2006). In addition, FDC-FcγRIIB plays a
major role in B-cell activation with Ag-specific and anti-BCR lig-
ation where the high density of FcγRIIB on FDCs binds Ig-Fc in
the IC and consequently the ITIM signal delivered via co-ligating
BCR and B-cell-FcγRIIB is minimized (Aydar et al., 2003, 2004b).
FDCs multimerize native Ags in a periodic manner as ini-
tially discovered using SEM with Ags trapped in vivo. Szakal et al.
reported patterns of orderly, spiraling, arrangement of ICs made
up of alternating light and dark bands (Szakal et al., 1985), and
recent studied of ICs trapping by FDCs in vitro confirmed Ag
periodicity (Sukumar et al., 2008) and indicated that ICs are
arranged on FDCs with a 200–500Å spacing between epitopes
which correlates well with spacing optimal for BCR crosslinking
and activation by TI type 2 Ags (Dintzis et al., 1976, 1983). The
periodically arranged ICs interact and “zip” processes together
which may help explain IC preservation and long-term retention
(Sukumar et al., 2008).
Using two-photon microscopy, it was recently shown that
the B-cell encounter with FDC-associated Ag could be detected
for >1 week after immunization. B-cell-FDC contact times were
often brief but occasionally persisted for >30min and B-cells
sometimes acquired Ag together with FDC surface proteins. These
observations establish that FDCs serve as sites of B-cell Ag cap-
ture, with their prolonged display time ensuring that even rare
B-cells have the chance of Ag encounter (Suzuki et al., 2009).
Persisting Ags on FDCs are critical for SHM which is impor-
tant for affinity maturation. SHM is a late GC event beginning
9–11 days after primary challenge, and a late specific Ag signal
(a week after priming) is delivered by Ags persisting on FDCs
to promote SHM and affinity maturation (Wu et al., 2008).
Moreover, Ags retained on FDCs are delivered to B-cells in the
form of iccosomes, which are highly immunogenic. Iccosomes
are readily endocytosed by GC B-cells, which process the Ag and
present it to T-cells (Szakal et al., 1988).
Strikingly, FDCs display Ags even in the presence of high lev-
els of specific Ab which might be expected to mask epitopes and
thus block successful Ag presentation. However, B-cells cluster
with FDCs forming a synapse at the point of FDC-B-cell contact
and Ag-specific B-cells recognize FDC-Ag via their BCRs in the
synapse even in the presence of high levels of Abs during the GC
reaction (El Shikh et al., 2009b).
B-cell costimulation
FDC-derived complement cosignals. In addition to presentation
of multimerized Ags in arrays that extensively crosslink BCRs,
FDCs provide costimultory signals that regulate Ig secretion in
TD and TI Ab responses. FDC-CD21L, -C4bBP, -BAFF, and -IL-6
are major FDC-molecules known to signal B-cells. The impor-
tant interaction between a complement-derived CD21 ligand on
FDCs and CD21 on B-cells in the initiation of IgG responses
has been well verified (Qin et al., 1998; Tew et al., 2001; Aydar
et al., 2005). Coligation of BCR andCD21 facilitates association of
BCR and B-cell co-receptor complex promoting CD19 phospho-
rylation by a tyrosine kinase associated with BCR (Carter et al.,
1997). This cosignal dramatically augments stimulation delivered
by engagement of BCR by Ag. Blockade of the CR2 ligand on
FDCs by the use of soluble CR2 or use of B-cells fromCR2 knock-
out mice (or B-cells with CR2 blocked) reduced Ab responses
10–1000 folds (Qin et al., 1998; Tew et al., 2001; Aydar et al.,
2005). FDCs from C3 knockout mice, which cannot generate the
CR2-binding fragments (iC3b, C3d, and C3dg), were unable to
provide costimulatory activity (Qin et al., 1998; Fakher et al.,
2001).
Not only do FDCs provide C3 (CD21L) as a complement
derived cosignal, but FDC-C4bBP has been recently reported to
engage B-cell CD40 and serve as a cosignal in FDC-dependent
TI responses to polysaccharides. TI polysaccharide Ags fix the
alternative complement pathway directly and the classical path-
way indirectly by making ICs with specific IgM produced early
in the response. In addition to accessory signals delivered by the
complement derived CD21L, activated forms of both C3 (C3b)
and C4 (C4b) bind C4 binding protein (C4BP), which in humans
and likely in rodents, colocalizes with ICs on FDCs. C4bBP in ICs
trapped on FDCs has been shown to signal B-cells via intact CD40
in short-lived Ag-specific TI GCs independent of T-cell derived
CD40L (CD154). More specifically, in mice with normal FDCs,
injection of a blocking mAb, FDC-M2, which recognizes an epi-
tope on C4 bound within ICs, also inhibited TI GC development.
C3- and C4-deficient mice showed impaired TI Ab responses
consistent with the hypothesis that ICs on FDCs can provide
Ag-specific, complement-derived, and CD40-mediated signals to
B-cells initiating B-cell proliferation in TI GCs (Gaspal et al.,
2006).
FDC-derived cytokines. FDCs produce BAFF (Hase et al., 2004;
Magliozzi et al., 2004; Zhang et al., 2005; El Shikh et al.,
2009a; Manzo et al., 2010) that has the ability to support TI
B-cell activation (Shulga-Morskaya et al., 2004; Groom et al.,
2007). FDC-BAFF is critical for FDC-dependent B-cell activation
(El Shikh et al., 2009a), and BAFF is directly involved in res-
cue, activation, and follicular homing of B-cells (Varin et al.,
2010). BAFF binds to BAFF-R, TACI (transmembrane activator
and calcium-modulator and cyclophilin ligand [CAML] interac-
tor) and, BCMA (B-cell maturation Ag). The functional outcome
of BAFF signaling is multifaceted and different receptors mediate
different functions. Peripheral B-cell survival, plasma cell sur-
vival, MZ-B-cell integrity, GC maintenance, CD21 and CD23
expression, TI B-cell responses and Ig class switching all have been
attributed to BAFF (Schneider, 2005).
Recent studies indicated a critical role for IL-6, whose pri-
mary source in GCs is FDCs (Kopf et al., 1998), in specific
IgG responses and SHM (Wu et al., 2009). IL-6, directly or via
IL-17, regulates B-cell activity (Deng et al., 2002), and block-
ing IL-6 from FDCs inhibits both IgG responses and SHM
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(Wu et al., 2009). FDC-BAFF, -IL-6, and -IL-15 can induce T-
cell IL-4, IL-5, IFNγ, and TNF-α (Mori et al., 1996; Heijink et al.,
2002; Huard et al., 2004; Park et al., 2004), and these cytokines
can indirectly promote B-cell activation and Ig class switching.
FDC-B-cell synapse. The integrity of the first BCR-mediated sig-
nal depends on extensive crosslinking of BCRs with IC-bearing
FDCs which likely entails formation of a properly functioning
FDC-B-cell synapse. FDC-CXCL-13 attracts follicular B-cells, and
in the spleen MZ-B-cells, and helps organize follicles (Cyster
et al., 2000; Estes et al., 2004). Within the follicles, the adhe-
sion molecules ICAM-1 and VCAM-1 are critical for FDC-B-cell
synapse formation and activation, and their blockade inhibits
FDC-B-cell clustering and B-cell activation (Kosco et al., 1992;
Maeda et al., 1995).
T independent B-cell activation
TI type 2 Ags trapped on FDCs can induce GCs in animals
lacking cognate T and B-cell interactions. When mice with muta-
tions that inactivate the TCR Cβ and Cδ genes were immu-
nized with 4-hydroxy-3-nitrophenylacetyl (NP)-Ficoll, GCs with
peanut agglutinin-binding B-cells were observed in the splenic
follicles. These GCs contained mature IC-bearing FDCs and
although they are rapidly induced, their duration is short (de
Vinuesa et al., 2000; Lentz and Manser, 2001). Nevertheless, the
finding that natural and synthetic multivalent Ags can induce Ig
secretion in the absence of T-cells does not mean that T-cells do
not play a part in TI responses and the involvement of several
T-cell cytokines has been established (Vos et al., 2000).
Typically ∼48 h is needed before primed T-cells are able to
provide cognate help and it is unlikely that cognate T helper cells
are involved in 48 h TI responses. It is important to appreciate
that IC activated FDCs produce BAFF and IL-6 and that these
cytokines can in turn rapidly induce cytokine production by T-
cells (Huard et al., 2001, 2004; Heijink et al., 2002). Owing to
their rapid intense cytokine production and their ability to pro-
vide B-cell help in a non-MHC-restricted fashion, γδ and NK
T-cells could help in the early phases of TI responses. IFN-γ-
mediated enhancement of Ig secretion has been demonstrated
by in vitro addition of γδ T-cell clones to anti-δ-dex stimulated
B-cells. Moreover, several reports indicate that pre-incubation of
purified B-cells with IL-4, a rapid product of activated NK T-
cells, prior to anti-δ-dex stimulation resulted in a 10-fold increase
in Ig secretion within 6 h. It has been also shown that prolifer-
ation of B-cells stimulated with slg-dependent (anti-μ-dex) or
-independent (LPS) polyclonal activators is markedly augmented
in vitro by addition of purified FDCs in a dose-dependent fashion
and cultures containing B-cells from athymic nude mice prolifer-
ated normally in the presence of anti-μ-dex plus rlL-4, implying
that IL-4 provides adequate help (Burton et al., 1993).
The ability of FDCs to convert TD Ags into TI Ags was recently
reported. TD Ags in ICs on FDCs are spaced 200–500 Å apart
on the flexible backbone of FDC membranes which is geometri-
cally fit for extensive BCR crosslinking. Moreover, FDCs provide
BAFF and C4bBP, which are known to support TI B-cell activa-
tion. Nude or athymic mice challenged with ICs produce specific
IgM in 48 hr while challenge with free Ag in adjuvant failed
to induce IgM even after many weeks. Moreover, the draining
lymph nodes of IC-challenged nude mice exhibit well-developed
GCs associated with FDC Ag retaining reticula and plasmablasts
within 48 h. IgM is the first class of Abs produced during primary
Ab responses, and the ability to induce FDC-dependent, TI IgM
responses may be critical in host defence in the initial phases of
infections before T-cell help is provided or in disease conditions
where T-cell insufficiency prevails (El Shikh et al., 2009a, 2010).
Major FDC regulatory and signaling molecules
Table 1 summarizes the currently characterized FDC regulatory
and signaling molecules.
FDC activation
Expression of FDC surface and secreted molecules is subject
to regulation, and engagement with ICs, TLR ligands, or col-
lagen type 1 induces FDC activation and upregulation of these
molecules. In the GCs, FDCs bear high levels of FcγRIIB, ICAM-
1, and VCAM-1, and these molecules are involved in converting
poorly immunogenic ICs into a highly immunogenic form and
facilitate FDC-B-cell interactions. FDC-trapped ICs (El Shikh
et al., 2006; Smith and Clatworthy, 2010), TLR ligands (El
Shikh et al., 2007b; Garin et al., 2010), and collagen type 1 (El
Shikh et al., 2007a) differentially upregulate the FDC accessory
molecules ICAM-1, VCAM-1, FcγRIIB, C4bBP, BAFF, IL-1β, IL-
10, and IL-6 (El Shikh et al., 2007b; Wu et al., 2009; Garin et al.,
2010).
Activated FDCs provide Ags to B-cells in a highly immuno-
genic form by: (1) multimerizing the Ags thus extensively
crosslink multiple BCRs (El Shikh et al., 2009a,b, 2010); (2) min-
imizing the inhibitory ITIM signaling in B-cells (Aydar et al.,
2004b; El Shikh et al., 2006, 2010); and (3) providing B-cell hom-
ing, survival, and costimulation signals in efficient FDC-B-cell
synapses (El Shikh et al., 2009b, 2010).
A major consequence of activation is a marked increase in
accessory activity. Both specific Ab responses and SHM are dra-
matically enhanced when FDCs are activated by TLR ligands sug-
gesting that adjuvant activity likely involves FDC-activation and
not just DC activation for T-cell co-stimulation (El Shikh et al.,
2007b; Wu et al., 2008). Moreover, TLR-mediated stimulation of
Peyer’s patches’ FDCs by bacterial products in the gut induces
FDC-CXCL13, -BAFF, and -TGF-β1 secretion and enhances IgA
production. Via TGF- β1, IgA, and other tissue-protective, anti-
inflammatory, and anti-tumor molecules, TLR-stimulated FDCs
uniquely regulate mucosal homeostasis and prevent excessive
activation that causes inflammation, autoimmunity, or tumor
formation in the gut (Suzuki et al., 2010). Recently, the non-
toxic CTA1-DD adjuvant hosting the ADP-ribosylating CTA1
subunit from cholera toxin and a dimer of the D fragment from
Staphylococcus aureus protein A was targeted to the FDC networks
and its deposition appeared to be complement-dependent. The
adjuvant directly activates complement, enabling binding of the
adjuvant to the FDC, which strongly promoted the GC reaction,
leading to augmented serum Ab titers and long-term memory
development. The mechanism of FDC activation by CTA1-DD
may be TLR-dependent or independent and this has to be further
verified (Mattsson et al., 2011).
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Table 1 | FDC regulatory and signaling molecules.
FDC molecule Function
BAFF FDC-BAFF supports TI B-cell activation (El Shikh et al., 2009a), and is required for the proper formation of FDC networks
within the GCs (Moisini and Davidson, 2009).
CD21/35 (CR1/2) CRs are crucial for IC retention especially in the spleen (Tew et al., 1979; Qin et al., 1997, 1998; Carroll, 1998; Barrington et al.,
2002). Genetic CD21 deficiency in humans adds to the molecular defects observed in human subjects with
hypogammaglobulinemia and severe reduction in memory B-cells (Thiel et al., 2012).
CD21L (iC3b, C3d or
C3dg)
Engagement of CD21 in the B-cell co-receptor complex by complement derived FDC-CD21L delivers a critical co-signal.
Coligation of BCR and CD21 facilitates association of the two receptors and the cytoplasmic tail of CD19 is phosphorylated by
a tyrosine kinase associated with the BCR complex. This co-signal augments stimulation delivered by Ag and blockade of
FDC-CD21L reduces B-cell proliferation, activation induced cytidine deaminase, and Ab production 10–1000 fold (Croix et al.,
1996; Fischer et al., 1996; Carroll, 1998; Qin et al., 1998; El Shikh et al., 2010).
CD23 (FcεRII) FDC-FcεRII mediates IC retention, and the regulation of the GC reaction and IgE levels (El Shikh et al., 2009b; Gibb et al., 2010;
Chaimowitz et al., 2011).
CD29, CD44 FDCs express CD44 and CD29 and FDC binding to collagen type I in vitro induces the regeneration of FDC processes and
networks. CD44 also enhances B-cell adherence to FDCs allowing delivery of the FDC-derived B-cell survival signals including
8D6 and BAFF (El Shikh et al., 2007a).
CD32 (FcγRIIB) FDC-FcγRIIB is critically involved in conversion of poorly immunogenic ICs into a highly immunogenic form, FDC activation, IC
periodicity, long-term IC retention, and regulation of serum IgG levels (El Shikh et al., 2009b, 2010).
CD320 (8D6) The 8D6 molecule inhibits apoptosis and influences both proliferation and Ab secretion by GC B-cells. Moreover, GC B-cells
that are induced to differentiate into pre-plasma cells are the most sensitive to the neutralizing effects of anti-8D6 (Zhang
et al., 2001; Li et al., 2004; Cho et al., 2008).
CD40 FDCs express CD40 and when incubated with either CD40L trimer or agonistic anti-CD40 Ab, the expression of FDC-CD23 is
increased both at the mRNA and protein levels. FDC-CD23 helps regulate IgE levels (Payet-Jamroz et al., 2001; Sukumar et al.,
2006a; Gibb et al., 2010).
CD54 (ICAM-1), CD106
(VCAM-1), MadCAM-1
Abs reactive with murine ICAM-1 and/or leukocyte functional Ag-I (LFA-I) interfere with FDC-B-cell clustering resulting in
reduced B-cell proliferation. In addition, VLA-4 and VCAM-1 have been observed in GCs and likely also play a role in FDC-B-cell
interactions. These adhesion molecules are thought to stabilize the FDC-B-cell synapse and promote interaction of FDC-Ag
and FDC-costimulatory molecules with B-cells (Kosco et al., 1992; Maeda et al., 1995; Vinuesa et al., 2010).
CXCL13 CXCL13 is secreted by FDCs and acts as chemoattractant for B-cells via the CXCR5 chemokine receptor. FDC development
and expression of this chemokine depend on LTαβ, and TNF-α. The maintenance of lymphoid follicle structure is mediated by a
positive feedback loop: CXCL13 stimulates B-cells to express high levels of LTαβ, and TNF-α which stimulates FDCs to
produce CXCL13 (Ansel et al., 2000; Cyster et al., 2000; Manzo et al., 2005; Wang et al., 2011).
Fcα/μR In humans, FDCs are the predominant cell type expressing Fcα/μR which are involved in IC retention (El Shikh et al., 2009b;
Honda et al., 2009).
FDC-M1 (Mfge8) Fat globule epidermal growth factor 8 (Mfge8) “licenses” tingible body macrophages (TBMs) to engulf apoptotic bodies in
GCs and helps minimize autoimmunity (Kranich et al., 2008).
FDC-M2 (C4b eptiope) C4b binding protein (C4bBP) binds C4b and co-localizes with ICs on FDCs. FDC-C4BP has been shown to signal B-cells via
CD40, independent of T-cell CD40L (CD154). Injection of mice with FDC-M2 inhibits C4BP development and TI-GC
development (Taylor et al., 2002).
Hedgehog (HH) ligand Sonic Hedgehog (SHH) ligand is produced by FDCs within the GCs of lymphoid follicles, and SHH ligand protects GCer B-cells
from apoptosis. GC B-cells express the HH receptors, and their survival is altered after inhibition of the HH signaling pathway
(Sacedon et al., 2005; Ok et al., 2012).
IL-15 IL-15 is produced by FDCs and is captured by IL-15R on the surface of FDCs. Surface IL-15 is active and promotes GC-B-cell
proliferation (Park et al., 2004), and human primary FDCs in vitro. In addition, blocking of FDC IL-15 signaling reduced FDC
secretion of CCL-2, CCL-5, CXCL-5 and CXCL-8, suggesting potentially important roles for recruitment of other cellular
components required for GC reaction (Gil et al., 2010).
IL-6 FDCs are the source of IL-6 in GCs. Engaging FDC-FcγRIIB by ICs activates FDCs and enhances FDC-IL-6 production.
FDC-IL-6 promotes GC development, IgG production, and SHM and terminal B-cell differentiation (Wu et al., 2009).
IL-7 IL-7 has been found in isolated tonsilar FDCs using RT-PCR and cell staining. IL-7 signaling coupled with crosslinking of
surface immunoglobulin receptors results in B-cell proliferation (Kroncke et al., 1996).
Notch ligands Notch ligands, Delta-like1 and Jagged 1, are expressed by FDCs and support GC-B-cell growth and survival (Yoon et al., 2009).
(Continued)
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Table 1 | Continued
FDC molecule Function
Prostaglandins (PGs) The role of PGs in regulation of the GC reaction has been suggested in the late 90s. TBM were found to be rich in PGs via
which they can downregulate the GC reaction (Smith et al., 1998). Recently, FDCs are identified as a source of PGs. Human
FDC-HK cell line produce PGE2 that is inhibted by COX-2 depletion (Cho et al., 2011a) and IL-4 via JAK1 and STAT6 signaling
pathway (Cho et al., 2011b, 2012b). Human FDC-PGs significantly enhance the expression levels of CD54, CD80, and CD86 on
the surface of activated B-cells and augment their Ag presentation activity (Kim et al., 2012b). Using a mouse FDC line, it was
also shown that IL-21 induces PGE2 secretion by FDCs (Magari et al., 2011).
TNFα-R and LT-R FDC development and maturation (Allen and Cyster, 2008)
TNF-α FDCs produced soluble TNF-α that promotos GC T-cell activation (Thacker et al., 2009).
Toll-like receptors (TLRs) Dramatic upregulation of FDC-ICAM-1, VCAM-1, and FcγRIIB is observed after injecting LPS into animals expressing WT TLR4
but not in animals with mutated TLR4. Incubation of FDCs with LPS in vitro upregulates FcγRIIB, ICAM-1, and VCAM-1. FDCs
express mRNA for TLR2, 3, 4 and 9 and injection of poly I:C brings up FDC-FcγRIIB to levels comparable with LPS (El Shikh
et al., 2007b). FDC activation via TLR4 enhances isotype switching, somatic hypermutation, and the production of high-affinity
Ig (Deshane and Chaplin, 2010; Garin et al., 2010).
Wnt5a FDCs secrete Wnt5a and its production is upregulated by polyI:C. FDC-Wnt5a is a GC B-cell survival factor and might be a
potential target for the regulation of B-cell immunity (Kim et al., 2012a).
FDCs IN THE PATHOGENESIS OF DISEASES
In addition to their contributions in regulated immunity, FDCs
also play important roles in pathological states, including
HIV/AIDS, prion diseases, autoimmunity and B-cell lymphomas.
FDCs IN AUTOIMMUNE DISEASES
Autoimmune disorders frequently display follicles with IC-
bearing FDCs, autoreactive GCs, and ongoing affinity matu-
ration (Aloisi and Pujol-Borrell, 2006; Manzo et al., 2010).
Moreover, FDCs retain ICs for years, and provide constant Ag
depot for memory B-cell re-stimulation (Klaus et al., 1980; Tew
et al., 1980; MacLennan and Gray, 1986; Gray, 1993; McHeyzer-
Williams et al., 1993; Bachmann and Jennings, 2010); and
interference with FDC-reticula attenuates autoreactive GC for-
mation, reduces pathogenic auto-Ab titers and memory B lym-
phocytes and ameliorates arthritis (Anolik et al., 2008; Victoratos
and Kollias, 2009; Vinuesa et al., 2009; Manzo et al., 2010).
It has been recently demonstrated that FDC follicular units in
rheumatoid arthritis synovium invariably express AID and are
surrounded by anti-citrullinated protein Ab (ACPA)-producing
plasma cells. This was further confirmed by evidence of sus-
tained AID expression, B-cell proliferation, ongoing CSR, and
production of human IgG ACPA from GC synovial tissue trans-
planted into SCID mice, independently of new B-cell influx
from the systemic circulation (Humby et al., 2009; Manzo et al.,
2010).
Data in various models and human studies suggests the
requirement for auto-Ag to sustain the autoimmune response
and that auto-Ag withdrawal inhibits it (Bach et al., 1998).
FDCs present Ags to B-cells in a highly immunogenic form and
membrane-bound Ags seem to be the predominant form of Ag
that mediates B-cell activation in vivo (Harwood and Batista,
2010).
In contrast to self-Ags of low valency such as small soluble pro-
teins, multivalent Ags crosslink BCRs, maintain downstream sig-
naling, and induce B-cell activation. In addition, tolerized B-cells
exhibit enhanced rates of BCR-mediated Ag uptake. However,
when the Ag is repetitive, stable, and resistant to BCR-mediated
endocytosis, like multimerized FDC-bound Ags, BCRs aggregate
and signaling is maintained. This results in clonal expansion and
Ab production that is dependent on the multitude of BCR sig-
nalosomes activated by extensive crosslinking of BCRs (Hinton
et al., 2008). The high levels of FcγRIIB on FDCs protects the
immunogenicity of FDC-ICs by minimizing serious inhibition of
B-cell activation upon BCR/FcγRIIB crosslinking (Aydar et al.,
2003, 2004b; El Shikh et al., 2006, 2009a). In fact, the expression
of FcγRIIB is significantly reduced on rheumatoid arthritis mem-
ory B-cells and plasmablasts and these alterations on FcγRIIB
were associated with high levels of anti-citrullinated vimentin
auto-Abs (Catalan et al., 2010).
Not only FDCs present Ags in a periodic multivalent ICs, but
also they provide complement-mediated B-cell co-stimulation
(Qin et al., 1998; Aydar et al., 2002; Barrington et al., 2002). CR2-
mediated complementation of BCR signals can overcome B-cell
anergy (Lyubchenko et al., 2007), and activation of the com-
plement system is involved in the pathogenesis of the systemic
autoimmune diseases via the classical pathway and the alternative
pathways (Chen et al., 2010).
Previous in vitro studies indicated that peripheral blood B-cells
from rheumatoid arthritis patients as well as healthy controls
can be induced in vitro to produce anti-CCP Abs using CD40L
polyclonal stimulation or in co-cultures with anti-CD3-activated
T-cells (Reparon-Schuijt et al., 2001). FDC-C4bBP is a B-cell
CD40L on activated FDCs, and infections at the onset of many
autoimmune diseases may directly activate FDCs by ligating
TLRs, and thus enhance FDC-B-cell interaction (El Shikh et al.,
2007b).
The initial Ab needed to trap Ag on FDCs may be induced by
molecular mimics or by polyclonal B-cell activation, which may
occur as a consequence of infections that herald many autoim-
mune diseases (Granholm and Cavallo, 1991; Sfriso et al., 2010).
However, once the ICs form, they would be trapped by FDCs and
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the autoreactive B-cells should be stimulated in a TI manner as
we have shown for foreign Ags in the absence of T-cells (El Shikh
et al., 2009a, 2010).
Polyvalent presentation of self-proteins in repetitive arrays
breaches B-cell tolerance in immune-tolerant animal models
(Sauerborn et al., 2010). Aggregated native hIFN-α broke B-cell
tolerance in transgenic mice (Hermeling et al., 2006), and virus-
like protein-arrayed HEL induced higher titer Ab responses
against HEL in tolerant HEL Tg mice (Chackerian et al., 2008;
Link and Bachmann, 2010). In certain occasions the high epitope
valency rendered Ab responses independent of CD21 (Jegerlehner
et al., 2002). Moreover, in humans, active immunization using
virus-like particle-based vaccines selectively targeting IL-17A,
soluble TNF-α or IL-1β has shown promising results in the pro-
tection against autoimmune arthritis and myocarditis in mouse
models (Spohn et al., 2005; Rohn et al., 2006; Sonderegger et al.,
2006; Spohn et al., 2007, 2008; Kopf et al., 2010).
FDCs IN HIV/AIDS
The contributions of FDCs to HIV pathogenesis include the stor-
age of a large and diverse reservoir of infectious virus, including
drug resistant variants, in an activated microenvironment where
CD4 T-cells targets are attracted but impaired in their ability to
leave thereby increasing the likelihood of their infection. Just as
Ags, intact HIV particles are found trapped on FDC dendritic
presented in the form of ICs containing Ab and/or complement
proteins. FDCs retain virus particles for long periods of time and,
in fact, as long as FDCs are present in infected individuals, HIV
can be found associated with them (Heath et al., 1995; Masuda
et al., 1995; Burton et al., 1997; Smith et al., 2001; Smith-Franklin
et al., 2002).
FDCs provide a microenvironment that is highly conducive to
HIV transmission. HIV ICs remain infectious for months, and
HIV on FDCs is “presented” to T-cells resulting in propagation of
infection. FDC-secreted TNF-α increases the rate of HIV tran-
scription by about three-fold in infected T-cells resulting in a
significant increase in virus production (Thacker et al., 2009).
FDCs also increase the T-cell expression of the HIV coreceptor
CXCR4 and these cells become highly susceptible to infection
with small quantities of virus that do not infect other cells with
lower levels of CXCR4. FDC-produced CXCL13 also contributes
to HIV pathogenesis by attracting HIV-susceptible T lymphocytes
into the lymphoid follicle (Estes et al., 2004).
FDCs IN PRION DISEASES
FDCs appear to play an important role in prion diseases as evi-
denced by the finding that in experimental models where FDCs
are not present, prion diseases do not typically appear. Prion
diseases occur in both animals and humans and are caused by
misfolded proteins encoded by the Prnp gene and consist of a nor-
mal form (PrPc) and its aberrant counterpart (PrPSc). Without
the normal PrPc protein, whose function is still unknown, the dis-
eases are notmanifest (Nuvolone et al., 2009; Aguzzi and Krautler,
2010).
Upon exposure to prions, the agents are transported into
secondary lymphoid tissues where the proteins accumulate and
replicate on FDCs. FDCs is a major source of PrPc and comple-
ment proteins play critical role in its retention. PrPc-expressing
FDCs are sufficient to sustain prion replication in the spleen
(McCulloch et al., 2011).
After prion replication in the secondary lymphoid tissues, the
PrPc-PRPSc complexes are transported to the central nervous
system where neurodegeneration occurs. The exact mechanism
of prion transport from FDCs to peripheral nerves is unknown.
Prions could be (1) transported by various cell types leaving
GCs toward nerve terminals; (2) incorporated by budding retro-
viruses; (3) released in FDC-derived iccosomes, or (4) passively
diffuse from the site of replication to the site of peripheral inner-
vation (Nuvolone et al., 2009). Recent studies indicate that B-cells
interacting with and acquiring surface proteins from FDCs and
recirculating between secondary lymphoid tissues via the blood
and lymph are involved in the initial propagation of prions
from the draining lymphoid tissue to peripheral tissues (Mok
et al., 2012). Because FDCs appear to be required for disease
pathogenesis in most cases, blocking agents to the LTβR path-
way, needed for FDC development and maintenance, results in
impaired development of disease suggesting the potential of this
approach in therapy (Nuvolone et al., 2009; Aguzzi and Krautler,
2010).
FDCs IN B-CELL LYMPHOMAS
Follicular lymphomas morphologically resemble conventional
GCs having B-cells, T-cells, macrophages, and FDCs. Recent stud-
ies suggest that the microenvironment in which the malignant
cells reside is critical for disease pathogenesis and progression.
The malignant cells appear to require the contributions of T-
cells, macrophages, and FDCs as evidenced by the observation
that in the absence of these cells, the malignant cells are dif-
ficult to survive. In addition to providing signals important to
tumor cell growth, FDCs also can provide signals that spare
malignant B-cells from undergoing apoptosis or programmed
cell death. Moreover, FDCs establish a protective sanctuary for
malignant cells from otherwise effective chemotherapeutic agents
(Asadullah et al., 2000; Li et al., 2004; Kim et al., 2012a; Lee et al.,
2012; Ok et al., 2012).
CONCLUDING COMMENTS
FDCs represent a unique accessory immune cell that provides
both Ag-driven and co-signals to B-cells. FDC-derived signals
contribute to the ability of B-cells to survive, proliferate, dif-
ferentiate, and produce optimal levels of specific high affinity
Abs during the GC reaction. Apart from their immunoregula-
tory functions, FDCs also contribute to several disease conditions
including autoimmune diorders, AIDS, prion diseases, and fol-
licular lymphomas. Further understanding of FDC biology is
essential for better control of humoral immunity and paves the
way for therapeutic management of FDC-mediated immune dis-
orders.
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